21 January 2026 - Top Stories

Australia's health technology landscape for January 2026 shows a clear tilt toward AI-enabled care, scalable data platforms and stronger integration between primary care and digital health tools. In AI-enabled health, Heidi has grown rapidly, supported by MongoDB Atlas and vector search, to handle 81 million medical consultations worldwide and provide a flexible data model that speeds development. Separately, the National Reconstruction Fund has committed $20 million in preferred equity to Omniscient Neurotechnology to push commercialization of Quicktome, its brain-mapping AI that uses MRI data and is already in routine use at leading hospitals after FDA approval.

Data sharing and patient access are moving to the fore. My Health Record is implementing default sharing, with pathology and diagnostic imaging reports uploading automatically. Patients will see pathology results as soon as they are uploaded, while other results appear within five days; from March 2026, X-ray limb reports move to immediate release, with clinicians retaining access to all reports. The reforms are designed to simplify workflows and test the system’s readiness for interoperable data flows across care settings.

Around care coordination, new interoperability models are taking shape. Eucalyptus has partnered with Consultmed to route GP‑linked care for Juniper, its GLP‑based weight‑loss programme, with direct GP referrals enabled from March 2026. Meanwhile, a broader narrative challenges the idea that GP access is shrinking, emphasising that digital tools and telehealth underpin continuity for patients in regional areas. In Tasmania, a fully funded domestic violence training program for GPs expands capacity to identify and respond to abuse in primary care settings.

Preventive care and screening are also moving up the policy agenda. Monash University researchers report findings from a 10 000‑person pilot showing 2 per cent carry high‑risk variants for conditions such as hereditary breast and ovarian cancer, Lynch syndrome or familial hypercholesterolaemia. Public funding for DNA testing remains narrow, and experts warn many high‑risk individuals go undetected under current arrangements. The results strengthen the case for a nationwide programme that would rely on GP integration, data governance and scalable workflows.

Policy and care design continue to emphasise patient‑centred approaches. Victoria’s RESPECT framework places a patient’s right to accept or decline care at the centre of maternity care, while a Productivity Commission report urges a shift toward prevention and early intervention to curb long‑term costs. Taken together, these developments point to a health‑tech landscape in Australia that combines AI, enhanced data sharing, and deeper primary-care involvement to improve outcomes and efficiency.

• NRFC funds Omniscient Neurotechnology to scale Quicktome brain mapping (US FDA‑approved) with a $20m preferred equity stake.
• Heidi’s AI scribe platform scales to 81 million medical consultations worldwide via MongoDB Atlas and vector search.
• My Health Record moves to default sharing; pathology/imaging uploads are automatic; five‑day imaging display window; March 2026 immediate release for X‑ray limb reports.
• Eucalyptus and Consultmed enable GP referrals to Juniper from March 2026, enhancing primary care involvement in weight management.
• Monash pilot finds 2% carry high‑risk variants; results bolster calls for a nationwide DNA screening programme with GP integration and governance needed.
• Victoria rolls out the RESPECT framework to strengthen birth‑care consent and communication.
• Productivity Commission urges prevention and early intervention, highlighting opportunities for outcome‑based funding and cross‑government health tech programs.